نتایج جستجو برای: thalassemia intermedia

تعداد نتایج: 23663  

2015
Paul J Schmidt Tim Racie Mark Westerman Kevin Fitzgerald James S Butler Mark D Fleming

β-thalassemias result from diminished β-globin synthesis and are associated with ineffective erythropoiesis and secondary iron overload caused by inappropriately low levels of the iron regulatory hormone hepcidin. The serine protease TMPRSS6 attenuates hepcidin production in response to iron stores. Hepcidin induction reduces iron overload and mitigates anemia in murine models of β-thalassemia ...

Journal: :Blood 1994
R Galanello S Barella M P Turco N Giagu A Cao F Dore N L Liberato R Guarnone G Barosi

Clinical data suggest that in beta-thalassemia-intermedia patients, higher levels of circulating fetal hemoglobin (HbF) are associated with greater disease severity at comparable degrees of anemia. We assessed the influence of the amount of circulating HbF on serum erythropoietin (s-Epo) levels and on serum transferrin receptor, a measure of erythropoiesis, in 30 beta-thalassemia-intermedia pat...

2009
Azita Azarkeivan Bashir Hajibeigi Seyed Moayed Alavian Maryam Moghani Lankarani Shervin Assari

BACKGROUND Using two logistic regression models, we determined the associates of poor physical and mental health related quality of life (HRQoL) among beta thalassemia patients. METHODS In this cross-sectional study which was conducted during 2006 and 2007 in outpatient adult thalassemia clinic, Blood Transfusion Organization, Tehran, Iran, Short Form 36 (SF-36) was used for measuring HRQoL i...

2015
Süha Akpınar Güliz Yılmaz Emre Çelebioğlu

Moyamoya disease is a cerebrovascular disorder with unknown cause characterized by the occlusion of the bilateral internal carotid arteries (ICA) and proximal segments of ICA.1,2 On the other hand, moyamoya syndrome (MMS) is a rare form of this condition with underlying several pathologies including hematologic disorders, congenital syndromes, vascular malformations or vasculitis after irradiat...

Journal: :Blood 1991
E A Rachmilewitz A Goldfarb G Dover

Patients with thalassemia major are considered to have high erythropoietin (Epo) activity.' However, Hammond et a1 reported that thalassemic patients had much less serum Epo activity compared with patients with hypoplastic anemia.* Determination of serum Epo levels in 32 patients from our clinic with homozygous p-thalassemia major and intermedia showed that Epo activity was not significantly hi...

Journal: :journal of research in medical sciences 0
sezaneh haghpanah hematology research center, shiraz university of medical sciences, shiraz, iran maryam davani hematology research center, shiraz university of medical sciences, shiraz, iran behrang samadi hematology research center, shiraz university of medical sciences, shiraz, iran afsaneh ashrafi a hematology research center, shiraz university of medical sciences, shiraz, iran. mehran karimi prof. of pediatric hematology ,hematology research center

background: beta-thalassemia is considered to be the most frequent hereditary blood disorder worldwide. lipid abnormalities have been detected in different types of beta-thalassemia . the aim of this study is to assess the lipid profiles in beta-thalassemia major (btm) and beta-thalassemia intermedia (bti) patients in southern iran. methods: the study group consisted of 55 btm patients and 50 b...

Journal: :archives of cardiovascular imaging 0
marzieh nikparvar assistant professor of cardiology, fellow of echocardiography, cardiovascular research center, hormozgan university of medical sciences, bandar abbas, ir iran nehzat akiash assistant professor of cardiology, fellow of echocardiography, atherosclerosis research center, ahvaz jundishapur university of medical sciences, ahvaz, ir iran; atherosclerosis research center, ahvaz jundishapur university of medical sciences, ahvaz, ir iran nader fayazi assistant professor of pulmonology, hormozgan university of medical sciences, bandar abbas, ir iran sepideh fouladi general physician, hormozgan university of medical sciences, bandar abbas, ir iran fatemeh jafary general physician, hormozgan university of medical sciences, bandar abbas, ir iran mahboubeh pazoki fellow of echocardiography, rasul akram general hospital, iran university of medical sciences, tehran, ir iran

conclusions the etiology of pah in thalassemia is multifactorial such as inflammatory mediators. also, the absence of the spleen plays an important role in developing a high trv and pah. results average age of the patients was 21.15 ± 6.68 years. no significant difference was observed in the pap between the 2 groups of thalassemia major and intermedia and also the 2 sex groups. indeed, 6.6% of ...

Journal: :Nihon Naika Gakkai Zasshi 1983

Journal: :American Journal of Hematology 2006

2003

Patients with thalassemia major are considered to have high erythropoietin (Epo) activity.' However, Hammond et a1 reported that thalassemic patients had much less serum Epo activity compared with patients with hypoplastic anemia.* Determination of serum Epo levels in 32 patients from our clinic with homozygous p-thalassemia major and intermedia showed that Epo activity was not significantly hi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید